Where do Immunome's ratios come from?

Every ratio is computed from Immunome's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Immunome IMNM Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Operating margin	-3,228.8%+154pp	-3,382.4%-2,601pp	-781.4%—	——
Net margin	-3,060%+180pp	-3,240.4%-2,478pp	-761.9%—	——
Returns
Return on equity	-52.1%+143pp	-194.6%-38.2pp	-156.5%-42.6pp	-113.8%-58.6pp
Efficiency
Asset turnover	0×0.0×	0×-0.1×	0.2×—	——
Liquidity
Current ratio	14.7×+10.6×	4.1×-2.6×	6.6×+3.5×	3.1×-2.7×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×—	——
Per Share
Book value per share	$7.26+135%	$3.09-48.9%	$6.04+340%	$1.37-67.1%
Valuation
Market capitalization	$2.37B+258%	$662.87M+45.0%	$457.21M+1,606%	$26.8M-82.9%
Price / sales	341.4×+268×	73.3×+40.7×	32.6×—	——
Price / book	3.7×+0.1×	3.7×-0.2×	3.8×+2.2×	1.6×-1.6×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Immunome.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Immunome's ratios come from?: Every ratio is computed from Immunome's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.